ARCHIVES

FDA Committee Okays Carboplatin For Second Line Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 15 No. 01 | January 6, 1989

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI Still Undecided Over Small Hospital Segment Of CHOP; Multihospital Proposals Review Nov. 14-15

November 2, 1979

In Brief: Holland Recovering From Coronary Bypass; Henry Kaplan Receives Annual Prentis Award

July 25, 1980

Intramural Funding To Decrease, R01s Increase, Klausner Says

September 15, 1995

NIAMDD Scientists Find Virus Gene Causes, Continues Cancer

May 9, 1975

FDA Approves Silicone Gel Breast Implants, Requires 10 Years Of Patient Follow-Up

November 24, 2006

White House Announces FDA Initiatives To accelerate Cancer Drug Approval

April 4, 1996